Rosuvastatin Market By Application, By Delivery Mode Type, By Geography – Global Industry Analysis, Growth, Share, Size, Trends, And Forecast 2019 – 2026

The Global Rosuvastatin Market is valued to grow at a healthy CAGR of 3.5% over the forecast period 2020-2026. Factors like increasing prevalence of obesity and other lifestyle related disorders, availability of generic products, development of health care and infrastructure coupled with increasing R&D investments are propelling the market growth.

Get Sample Report: Rosuvastatin Market

As the market witness an increase in rise in hospital admissions due to cardiovascular disease, it is also a major cause of premature death and disability in advanced countries. As the trend gains a traction in developing countries, cardiovascular diseases are causing a huge economic burden and hence efforts for controlling the consequences are highly evident. Major features of rosuvastatin include, high absorption, metabolism and distribution based on their form and availability. As an inhibitor, affinity level for rosuvastatin is likely to be higher than the generics. Depending on the mode of distribution, it is basically distributed to hepatocytes in cases of low peripheral concentrations.

From the commercial stanpoint, intake of rosuvastatin does not lead to any major side effects but can exhibit minor abnormalities such as nausea, weakness, muscle pain and vomiting. For such health conditions, doctor advice is recommended before taking up any clinical trial.

Rosuvastatin Market Trends, Drivers and Opportunities:

Rosuvastatin market is significantly driven by growing prevalence of obesity and rise in lifestyle related disease. Government initiatives and favorable policies for healthcare in developed countries is likely to trigger the market demand. In addition, availability of generic products and investments for R&D is likely to project growth opportunities for market development in the near future. On contrary, stringent policies and regulatory norms are likely to hinder the market growth in the forecast period.